Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/33090
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-21T06:29:38Z | - |
dc.date.available | 2023-06-21T06:29:38Z | - |
dc.date.issued | 2013-01-17 | - |
dc.identifier.citation | Sezgin, M. E. vd. (2014). "Childhood immune thrombocytopenia: Long-term follow-up data evaluated by the criteria of the international working group on immune thrombocytopenic purpura". Turkish Journal of Hematology, 31(1), 32-39. | tr_TR |
dc.identifier.issn | 1300-7777 | - |
dc.identifier.issn | 1308-5263 | - |
dc.identifier.uri | https://doi.org/10.4274/Tjh.2012.0049 | - |
dc.identifier.uri | https://jag.journalagent.com/tjh/pdfs/TJH_31_1_32_39.pdf | - |
dc.identifier.uri | http://hdl.handle.net/11452/33090 | - |
dc.description.abstract | Objective: Immune thrombocytopenia (ITP) is a common bleeding disorder in childhood, characterized by isolated thrombocytopenia. The International Working Group (IWG) on ITP recently published a consensus report about the standardization of terminology, definitions, and outcome criteria in ITP to overcome the difficulties in these areas. Materials and Methods: The records of patients were retrospectively collected from January 2000 to December 2009 to evaluate the data of children with ITP by using the new definitions of the IWG. Results: The data of 201 children were included in the study. The median follow-up period was 22 months (range: 12-131 months). The median age and platelet count at presentation were 69 months (range: 7-208 months) and 19x10(9)/L (range: 1x10(9)/L to 93x10(9)/L), respectively. We found 2 risk factors for chronic course of ITP: female sex (OR=2.55, CI=1.31-4.95) and age being more than 10 years (OR=3.0, CI=1.5-5.98). Life-threatening bleeding occurred in 5% (n=9) of the patients. Splenectomy was required in 7 (3%) cases. When we excluded 2 splenectomized cases, complete remission at 1 year was achieved in 70% (n=139/199). The disease was resolved in 9 more children between 12 and 90 months. Conclusion: Female sex and age above 10 years old significantly influenced chronicity. Therefore, long-term follow-up is necessary in these children. | en_US |
dc.description.abstract | Gereç ve Yöntemler: ITP’li hastalarımıza ait kayıtlar Ocak 2000’den Kasım 2009’a kadar, geriye yönelik olarak, IWG’nin yeni kriterleri kullanılarak değerlendirilmek üzere toplandı. Bulgular: İki yüz bir çocuğun verileri çalışmaya dahil edildi. Ortanca takip süresi 22 ay (12-131 ay) idi. Başvuru anında ortanca yaş ve trombosit sayısı, sırası ile 69 ay (7-208 ay) ve 19x109/L (1-93x109/L) idi. Hastalığın kronikleşmesi açısından iki risk faktörü saptadık: Kız cinsiyet (OR=2,55, CI=1,31-4,95) ve yaşın 10’dan büyük olması (OR=3,0, CI=1,5-5,98). Hayatı tehdit edici kanama, hastaların 5%’inde (n=9) görüldü. Splenektomi yapılması,7 hastada (3%) gerekti. İlk bir yılda splenektomi yapılan 2 hasta göz ardı edildiğinde, tam remisyon (CR) 70% (n=139/199) hastada görüldü. Hastalık, kronik ITP’li olguların 9’unda (%15; 9/60) daha tanıdan itibaren12 ile 90 ay içerisinde düzeldi. Sonuç: Kız cinsiyet ve yaşın 10’dan büyük olması, kronikleşmeyi belirgin olarak etkiledi. Ancak bu çocuklarda uzun sureli takip gereklidir | tr_TR |
dc.language.iso | en | en_US |
dc.publisher | Galenos Yayıncılık | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Children | en_US |
dc.subject | Thrombocytopenia | en_US |
dc.subject | Long-term survival | en_US |
dc.subject | Natural-history | en_US |
dc.subject | Clinical characteristics | en_US |
dc.subject | Management | en_US |
dc.subject | Children | en_US |
dc.subject | Splenectomy | en_US |
dc.subject | Itp | en_US |
dc.subject | Diagnosis | en_US |
dc.subject | Hematology | en_US |
dc.subject | Trombositopeni | tr_TR |
dc.subject | Çocuk | tr_TR |
dc.subject | Uzun dönem takip | tr_TR |
dc.title | Childhood immune thrombocytopenia: Long-term follow-up data evaluated by the criteria of the international working group on immune thrombocytopenic purpura | tr_TR |
dc.title.alternative | Çocukluk Çağında İmmun Trombositopeni: Uluslararası İmmun Trombositopeni Çalışma Grubunun Kriterlerine Göre Uzun İzlem Verilerinin Değerlendirilmesi | tr_TR |
dc.type | Article | en_US |
dc.identifier.wos | 000347435400005 | tr_TR |
dc.identifier.scopus | 2-s2.0-84905918527 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Hematoloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 32 | tr_TR |
dc.identifier.endpage | 39 | tr_TR |
dc.identifier.volume | 31 | tr_TR |
dc.identifier.issue | 1 | tr_TR |
dc.relation.journal | Turkish Journal of Hematology | en_US |
dc.contributor.buuauthor | Sezgin, Melike Evim | - |
dc.contributor.buuauthor | Baytan, Birol | - |
dc.contributor.buuauthor | Güneş, Adalet Meral | - |
dc.contributor.researcherid | AAH-1452-2021 | tr_TR |
dc.indexed.trdizin | TrDizin | tr_TR |
dc.identifier.pubmed | 24764727 | tr_TR |
dc.subject.wos | Hematology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 36667380300 | tr_TR |
dc.contributor.scopusid | 6506622162 | tr_TR |
dc.contributor.scopusid | 24072843300 | tr_TR |
dc.subject.scopus | Idiopathic Thrombocytopenic Purpura; Romiplostim; Thrombocytopenia | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Childhood disease | en_US |
dc.subject.emtree | Childhood immune thrombocytopenia | en_US |
dc.subject.emtree | Chronicity | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Coombs test | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Hepatitis b rapid test | en_US |
dc.subject.emtree | Hepatitis c rapid test | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Idiopathic thrombocytopenic purpura | en_US |
dc.subject.emtree | Infant | en_US |
dc.subject.emtree | Long term survival | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Medical record review | en_US |
dc.subject.emtree | Mucosal bleeding | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.emtree | Splenectomy | en_US |
dc.subject.emtree | Thrombocyte count | en_US |
dc.subject.emtree | Thrombocytopenia | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Immunoglobulin g | en_US |
dc.subject.emtree | Prednisone | en_US |
Appears in Collections: | Scopus TrDizin Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Evim_vd_2014.pdf | 157.39 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License